1
|
He JY, Gui B, Chen YF, Yin YQ, Tao SH, Shen ZB, Li KP, Fu JB, Wei L. [Mechanism of Liangfu Pills in treatment of functional dyspepsia: based on network pharmacology and experimental verification]. Zhongguo Zhong Yao Za Zhi 2022; 47:3853-3862. [PMID: 35850844 DOI: 10.19540/j.cnki.cjcmm.20211230.705] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
This study aims to explore the potential mechanism of Liangfu Pills in the treatment of functional dyspepsia(FD) based on network pharmacology and molecular docking, and verify the mechanism by animal experiment. The active components of Liangfu Pills were screened from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP), and the targets of Liangfu Pills were predicted by SwissTargetPrediction. The targets of FD were retrieved from GeneCards. On this basis, the common targets of the disease and the pills were yielded and the protein interaction was retrieved based on STRING. The core targets were screened out, followed by Gene Oncology(GO) term enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analysis with DAVID. Finally, molecular docking was carried out with the help of AutoDock Tools to predict the binding degree between the effective components of Liangfu Pills and core targets. A total of 19 active components of Liangfu Pills and 591 FD-related targets were screened out by network pharmacology, of which 253 were common targets of the disease and the prescription. Liangfu Pills was mainly involved in the biological processes of response to drug, negative regulation of transcription, positive regulation of apoptotic process, and cell surface receptor signaling pathway, and the KEGG pathways of hypoxia-inducible factor-1(HIF-1) signaling pathway, serotonergic synapse, tumor necrosis factor(TNF) signaling pathway, cyclic adenosine monophosphate(cAMP) signaling pathway, calcium signal pathway, and inflammatory mediator regulation of transient receptor potential(TRP) channels. The results of molecular docking showed that the key active components of Liangfu Pills had certain binding activity to the targets mitogen-activated protein kinase 1(MAPK1), protein kinase B(AKT1), transient receptor potential cation channel subfamily V member 1(TRPV1), 5-hydroxytryptamine receptor 1 A(HTR1 A), and 5-hydroxytryptamine receptor 2 A(HTR2 A). FD was induced in rats, and then Liangfu Pills was given to FD rats for 7 days. The results showed that Liangfu Pills could significantly relieve the symptoms of FD rats, significantly increase the expression of 5-hydroxytryptamine(5-HT), and down-regulate the expression of TRPV1. Through network pharmacology, molecular docking, and experimental verification, this study proved that Liangfu Pills improved FD through multiple components and multiple targets. The result lays a basis for further research on the mechanism and clinical application of Liangfu Pills in the treatment of FD.
Collapse
Affiliation(s)
- Jie-Ying He
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Bei Gui
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Yan-Fen Chen
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Yong-Qin Yin
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Shu-Hong Tao
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Zhi-Bin Shen
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Kun-Ping Li
- Institute of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Jiang-Bo Fu
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| | - Ling Wei
- School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510006, China
| |
Collapse
|
2
|
Wu GY, Fu JB, Luo YZ, Yan W, Hong XQ, Kuang PH, Lin ED, Lin FS, Song ZF, Chen JY, Fu YL. [Endoscopic lateral neck dissection via the breast and transoral approaches for papillary thyroid carcinoma: a report of 10 cases]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021; 56:751-754. [PMID: 34344103 DOI: 10.3760/cma.j.cn115330-20201015-00805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the feasibility of endoscopic lateral neck dissection via the breast and transoral approaches (ELNDBTOA) for papillary thyroid carcinoma (PTC). Methods: From February 2015 to April 2019, 10 patients with PTC (cN1b) including 1 male and 9 females aged from 22 to 53 years old received ELNDBTOA in the General Surgery Department of Zhongshan Hospital, Xiamen University. Total thyroidectomy, the central lymph node dissection and the selective neck dissection (levels Ⅱ, Ⅲ and Ⅳ) were performed endoscopically via the breast approach, and then the residual lymph nodes were dissected via transoral approach. The medical records, operation time, blood loss, complications and postoperative follow-up outcomes were analyzed retrospectively. SPSS 22.0 software package was used for statistical processing of clinical data of patients. Results: All cases were successfully treated with ELNDBTOA without transfer to open surgery. The average operative time was (362.5±79.7) min, the blood loss was (23.0±14.9) ml, and the postoperative hospital stay was (5.1±1.3) days. The mean number of harvested cervical lymph nodes were (34.2±25.8), and the mean number of positive lymph nodes were (6.5±4.9). Lymph nodes were dissected by the further dissection via oral approach in 6 patients and a total of 9 lateral lymph nodes were havested from 2 of the 6 patients, with 3 positive lymph nodes. Two patients had transient skin numbness in the mandibular area and recovered within two weeks. One patient developed transient hypoparathyroidism and recovered within two months. No secondary bleeding, recurrent laryngeal nerve paralysis, chylous leakage, neck infection, permanent hypoparathyroidism or other complications were observed. The follow-up time was from 16 to 66 months with a median of 42.5 months, no tumor recurrence or metastasis occurred, and also no obvious deformity, abnormal sensation or movement in the chest, neck and mouth was observed. Conclusions: ELNBTOA is safe and feasible, with good cosmetic outcome.
Collapse
Affiliation(s)
- G Y Wu
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - J B Fu
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - Y Z Luo
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - W Yan
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - X Q Hong
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - P H Kuang
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - E D Lin
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - F S Lin
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - Z F Song
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - J Y Chen
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| | - Y L Fu
- Department of General Surgery, Zhongshan Hospital, Xiamen University, Xiamen 361004, China
| |
Collapse
|
3
|
Morishita S, Tsubaki A, Fu JB, Mitobe Y, Onishi H, Tsuji T. Cancer survivors exhibit a different relationship between muscle strength and health-related quality of life/fatigue compared to healthy subjects. Eur J Cancer Care (Engl) 2018; 27:e12856. [PMID: 29767832 DOI: 10.1111/ecc.12856] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2018] [Indexed: 01/22/2023]
Abstract
We investigated the difference in relationship between muscle strength and quality of life (QOL)/fatigue in long-term cancer survivors and healthy subjects. Thirty-six cancer survivors and 29 healthy subjects were assessed for body composition and bone status at the calcaneus using the Osteo Sono Assessment Index. Muscle strength was evaluated via handgrip and knee extensor strength. Health-related QOL was assessed using the Medical Outcome Study 36-item Short-Form Health Survey. Fatigue was measured using the brief fatigue inventory. Cancer survivors exhibited lower QOL scores in the physical functioning, physical role function, bodily pain and general health domains (p < .05). Grip and knee extension muscle strength in cancer survivors was positively correlated with the physical function and bodily pain of QOL (p < .05). The usual fatigue subscale score was only significantly higher in cancer survivors than in healthy subjects (p < .05). However, there were no correlations between muscle strength and fatigue in cancer survivors. Our results showed that muscle strength was an important factor for improving QOL in cancer survivors. We believe that the findings of this study will be relevant in the context of planning rehabilitation for cancer survivors.
Collapse
Affiliation(s)
- S Morishita
- Institute for Human Movement and Medical Sciences, Niigata University of Health and Welfare, Niigata, Japan
| | - A Tsubaki
- Institute for Human Movement and Medical Sciences, Niigata University of Health and Welfare, Niigata, Japan
| | - J B Fu
- Department of Palliative, Rehabilitation and Integrative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Y Mitobe
- Department of Nursing, Niigata University of Health and Welfare, Niigata, Japan
| | - H Onishi
- Institute for Human Movement and Medical Sciences, Niigata University of Health and Welfare, Niigata, Japan
| | - T Tsuji
- Department of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan
| |
Collapse
|